Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Department of Rehabilitation, the Third Affiliated Hospital and Lingnan Hospital of the Sun Yat-Sen University, Guangzhou, China.
Eur J Pain. 2022 Jul;26(6):1234-1244. doi: 10.1002/ejp.1942. Epub 2022 Mar 28.
Bladder pain syndrome/interstitial cystitis (BPS/IC) is a refractory disease accompanied by bladder-related pain and hyperactivity. Studies have shown that the translocator protein (TSPO) modulates neuroinflammation and central sensitisation associated with pain. Moreover, we previously demonstrated that brain-derived neurotrophic factor (BDNF) regulates neuroinflammation and mechanical allodynia in cyclophosphamide (CYP)-induced cystitis through activation of glial cells. Here, we aimed to explore whether activation of TSPO attenuates mechanical allodynia and bladder dysfunction by regulating BDNF induced neuroinflammation in a CYP-induced cystitis model.
Injection of CYP was performed to form a rat model of BPS/IC. The expression of TSPO was regulated by intrathecal injection of the TSPO agonist Ro5-4864. The von Frey filament test was applied to evaluate suprapubic allodynia. Bladder function was assessed using filling cystometry. Western blotting was used to detect the expression of TSPO, BDNF, GFAP, Iba-1, p-p38, p-JNK, TNF-α, and IL-1β, and double immunofluorescence was performed to localise TSPO in the L6-S1 spinal dorsal horn (SDH).
TSPO was activated in the SDH after CYP injection and was primarily colocalised with astrocytes. Ro5-4864 reversed mechanical allodynia and bladder dysfunction induced by CYP. Moreover, the upregulation of BDNF and activation of astrocytes and microglia was suppressed by Ro5-4864, resulting in downregulation of p-p38, p-JNK, TNF-α, and IL-1β.
Ro5-4864 alleviated mechanical allodynia and bladder dysfunction in the CYP model, possibly by inhibiting the elevation of BDNF and consequent activation of astrocytes and microglia induced neuroinflammation. TSPO may be a potential target for the treatment of BPS/IC.
This study examined the mechanism underlying the ability of the translocator protein to modulate bladder pain syndrome/interstitial cystitis.
膀胱疼痛综合征/间质性膀胱炎(BPS/IC)是一种伴有膀胱相关疼痛和过度活动的难治性疾病。研究表明,转位蛋白(TSPO)调节与疼痛相关的神经炎症和中枢敏化。此外,我们之前的研究表明,脑源性神经营养因子(BDNF)通过激活神经胶质细胞调节环磷酰胺(CYP)诱导的膀胱炎中的神经炎症和机械性痛觉过敏。在这里,我们旨在探讨 TSPO 激活是否通过调节 CYP 诱导的膀胱炎中 BDNF 诱导的神经炎症来减轻机械性痛觉过敏和膀胱功能障碍。
注射 CYP 构建大鼠 BPS/IC 模型。通过鞘内注射 TSPO 激动剂 Ro5-4864 调节 TSPO 的表达。应用 Von Frey 细丝试验评估耻骨上痛觉过敏。使用充盈膀胱测压法评估膀胱功能。采用 Western blot 检测 TSPO、BDNF、GFAP、Iba-1、p-p38、p-JNK、TNF-α和 IL-1β的表达,并进行双免疫荧光定位 TSPO 在 L6-S1 脊髓背角(SDH)中的表达。
CYP 注射后 SDH 中 TSPO 被激活,主要与星形胶质细胞共定位。Ro5-4864 逆转了 CYP 诱导的机械性痛觉过敏和膀胱功能障碍。此外,Ro5-4864 抑制了 BDNF 的上调和星形胶质细胞和小胶质细胞的激活,导致 p-p38、p-JNK、TNF-α和 IL-1β的下调。
Ro5-4864 减轻了 CYP 模型中的机械性痛觉过敏和膀胱功能障碍,可能是通过抑制 BDNF 的升高和随后的星形胶质细胞和小胶质细胞激活引起的神经炎症。TSPO 可能是治疗 BPS/IC 的潜在靶点。
本研究探讨了转位蛋白调节膀胱疼痛综合征/间质性膀胱炎的机制。